Stop using now Drug recall · FDA · Published September 19, 2024

Gilead Veklury injection recall: Glass particles risk serious injury

Gilead recalls Veklury (remdesivir) injections due to glass particles that could cause serious injury. Affected lots: 47035CFA, expiring 11/2025. Stop using immediately.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0005-2025Drug Gilead ›

Stop using this now

Presence of Particulate Matter: Presence of glass particle.

Take action

Contact the company

Recalling firmGilead Sciences, Inc.333 Lakeside Dr · Foster City, CA 94404-1147

✎ GovInfoNow plain-language explainer

Gilead is recalling Veklury injections because they may contain glass particles that could cause serious injury. This affects patients receiving the medication for certain infections. If you have this product, stop using it immediately. Read more at govinfonow.com/recall/32538-gilead-veklury-injection-recall-glass-particles-risk-serious-injury.

Source Summary by GovInfoNow · govinfonow.com/recall/32538-gilead-veklury-injection-recall-glass-particles-risk-serious-injury · Updated August 17, 2026 · FDA enforcement record: FDA #D-0005-2025

Cite this page

“Gilead Veklury injection recall: Glass particles risk serious injury.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32538-gilead-veklury-injection-recall-glass-particles-risk-serious-injury. Based on FDA recall #D-0005-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0005-2025%22&limit=1).

Gilead Sciences, Inc. recalled Veklury (remdesivir) for injection due to the presence of glass particulate matter, according to the FDA. The agency announced the Class I recall on September 19, 2024.

How to tell if you have it

Brand: Gilead
Product: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial
NDC: 61958-2901-2
Lot: 47035CFA
Expiration: 11/2025

The hazard

The recall addresses the presence of particulate matter, specifically glass particles, in the product. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Gilead Sciences, Inc. has 6 other recalls on record since 2013-01-31. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (2026-08-10), Mallinckrodt Acthar Gel 5mL Vial Recall (2026-08-06), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (2026-05-12).

How to tell if you have this one

Check the vial label for the lot number 47035CFA and expiration date 11/2025. The product is a 100 mg/vial injection for medical use only.

Brand
Gilead
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Immediately
Discard the vial if you have the lot number 47035CFA or expiration date 11/2025.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

Sep 19, 2024Firm started the recall
Oct 3, 2024FDA classified it Class I
Oct 9, 2024Published in FDA’s Enforcement Report
Jul 29, 2025FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32538-gilead-veklury-injection-recall-glass-particles-risk-serious-injury">Gilead Veklury injection recall: Glass particles risk serious injury (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0005-2025 (September 19, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0005-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.